Merck announced the U.S. Food and Drug Administration (FDA) approved supplemental New Drug Applications (sNDAs) for PIFELTRO? (in combination with other antiretroviral agents) and DELSTRIGO? ...
MSD’s HIV medicines Delstrigo and Pifeltro have been cleared by the US Food and Drug Administration for adult patients with no prior antiretroviral treatment experience.